We need your support to keep TheyWorkForYou running and make sure people across the UK can continue to hold their elected representatives to account.

Donate to our crowdfunder

Haemophilia: Medical Treatments

Department of Health and Social Care written question – answered on 18th October 2018.

Alert me about debates like this

Photo of Diana R. Johnson Diana R. Johnson Labour, Kingston upon Hull North

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 September 2018 to Question 167276 on haemophilia: medical treatments, whether those savings have been reinvested in supporting the haemophilia community; and whether any savings in the devolved nations of the UK have accrued to (a) NHS England or (b) the devolved administrations.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The National Health Service achieves savings across all clinical services, and reinvests those savings within its overall expenditure limits set by parliament. The NHS does not usually ring fence funding for specific patient groups, but considers its funding responsibilities for all patients based on all sources of funding, including procurement savings. Savings from medicines used by the devolved administrations remain within those administrations.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.